FYERS
Home
/
Stocks
/
Results
/
Fischer Medical Ventures Results

Fischer Medical Ventures Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--1098%179%
---1743%
----70%
4%4%5%9%

Peer Comparison

Symbol
ADANIENT
AEGISLOG
CPPLUS
PREMIERENE
REDINGTON
HONASA
LLOYDSENT
SGMART
MMTC
EBGNG
FISCHER
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
2,900₹404763 Cr54.37-8.91105.06₹9339 Cr
1,369.7₹49337 Cr39.4313.841.65₹898 Cr
3,800.1₹45264 Cr94.8412.0745.29₹368 Cr
898₹41326 Cr24.8210.245.28₹1510 Cr
406.4₹31353 Cr18.436.2224.36₹1490 Cr
472.95₹15804 Cr63.52.778.99₹200 Cr
75.58₹11326 Cr100.860.380.91₹283 Cr
717.15₹9230 Cr74.243.6210.96₹111 Cr
57.97₹9063 Cr20.260.693.01₹387 Cr
676.65₹8154 Cr57.252.5413.51₹132 Cr
34.4₹2448 Cr82.060.060.48₹30 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023
————
₹65 Cr₹64 Cr₹54 Cr₹17 L
₹26 Cr₹30 Cr₹87 L₹0
₹293 Cr₹243 Cr₹27 Cr-₹44 L
₹293 Cr₹243 Cr₹27 Cr-₹44 L
₹384 Cr₹338 Cr₹81 Cr-₹27 L
₹76 L₹34 L₹0₹0
₹0₹0₹0₹57 L
₹26 L₹26 L₹0₹0
-₹2 Cr₹53,000₹12 L-₹11 L
₹27 Cr₹17 Cr₹1 Cr₹0
₹99 L₹9 L₹0₹0
₹26 Cr₹17 Cr₹1 Cr₹47 L
————
₹103 Cr₹21 Cr₹2 Cr₹1 L
₹23 Cr₹23 Cr₹2 Cr₹3 L
₹72 Cr₹60 Cr₹0₹0
₹61 Cr₹1 Cr₹90,000₹0
₹258 Cr₹105 Cr₹4 Cr₹5 L
₹669 Cr₹461 Cr₹86 Cr₹25 L
₹72 Cr₹60 Cr₹0₹57 L
————
₹38 Cr₹27 Cr₹16 Cr₹0
₹6 Cr₹3 Cr₹1 Cr₹0
₹32 Cr₹24 Cr₹15 Cr₹0
₹3 Cr₹1 Cr₹0₹0
₹118 Cr₹7 Cr₹1 Cr₹0
₹118 Cr₹7 Cr₹1 Cr₹0
₹50 Cr₹22 Cr₹0₹0
₹49 Cr₹38 Cr₹0₹0
₹251 Cr₹92 Cr₹16 Cr₹0
————
₹13 Cr₹9 Cr₹4 Cr₹0
₹289 Cr₹76 Cr₹23 Cr₹17 L
₹25 Cr₹255 Cr₹38 Cr₹4 L
₹6 Cr₹3 Cr₹45 L₹0
₹86 Cr₹26 Cr₹5 Cr₹4 L
₹418 Cr₹369 Cr₹70 Cr₹25 L
₹160 Cr₹263 Cr₹67 Cr₹20 L
₹669 Cr₹461 Cr₹86 Cr₹25 L
₹5₹48₹15-₹15
₹5₹5₹1-₹2

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Cash & Cash Equivalent of Subsidiaries under liquidations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023
₹45 Cr₹2 Cr₹2 Cr₹0
₹15 Cr₹3 Cr₹25 L₹0
-₹144 Cr-₹90 Cr-₹10 Cr₹0
-₹84 Cr-₹85 Cr-₹7 Cr₹0
-₹101 Cr-₹86 Cr-₹7 Cr₹0
-₹5 Cr-₹125 Cr-₹31 Cr₹0
₹14 Cr₹315 Cr₹37 Cr₹0
-₹92 Cr₹103 Cr-₹2 Cr₹0
₹104 Cr₹95 L₹4 L₹0
₹0₹0₹3 Cr₹0
₹0₹50,000₹0₹0
₹12 Cr₹104 Cr₹95 L₹0

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)34.98
Volume (₹)5.05 L
High (₹)35.01
Upper Circuit42.03
Low (₹)33.86
Lower Circuit28.03
Prev Close35.03
52W High (₹)124.70
Price34.40
52W Low (₹)31.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)2447.50 Cr
Div. Yield (%)0.14
PE Ratio82.06
Debt to Equity0.20
Price to Book7.38
Book Value5.48
EPS (TTM)0.43
Face Value1.00
ROE (%)9.38

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
ADANIENTNSE
AEGISLOGNSE
CPPLUSNSE
PREMIERENENSE
REDINGTONNSE
HONASANSE
LLOYDSENTNSE
SGMARTNSE
MMTCNSE
EBGNGNSE
FISCHERNSE
LTP
1W Low
1W High
Market cap (₹)
2900-120 (-3.97%)
2898.20
3026.10
4,04,763Cr
1369.7-45.7 (-3.23%)
1348.40
1528.70
49,337Cr
3800.1+445 (13.26%)
3338.80
3874.60
45,264Cr
898-4 (-0.44%)
885
920
41,326Cr
406.4+6.55 (1.64%)
390.70
419.50
31,353Cr
472.95-6.6 (-1.38%)
465.55
492
15,804Cr
75.58+6.74 (9.79%)
67.23
77.15
11,326Cr
717.15-16.4 (-2.24%)
710.05
747.85
9,230Cr
57.97-2.3 (-3.82%)
57.45
60.99
9,063Cr
676.65-26.4 (-3.76%)
671.90
730
8,154Cr
34.4+1.25 (3.77%)
32.50
36.15
2,448Cr

Fischer Medical Ventures Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹12.73Cr; with other income of ₹1.48Cr, profit before interest and tax came to ₹11.38Cr. Interest expense was ₹3.54Cr; PBT before exceptional items stood at ₹7.83Cr. Cost mix (full year): raw materials ₹96.27Cr; employee cost ₹2.58Cr; depreciation ₹1.36Cr; other expenses ₹70.67Cr. Basis: consolidated annual results.

Fischer Medical Ventures Ltd Quaterly Results Key Takeaways

Fischer Medical Ventures Ltd reported ₹81.92Cr total income from operations in Jun 2026, softer than ₹97.73Cr in Mar 2026 but higher than ₹23.45Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹12.73Cr; with other income of ₹1.48Cr, profit before interest and tax came to ₹11.38Cr. Interest expense was ₹3.54Cr, taking profit before tax to ₹7.83Cr. After tax of ₹4.04Cr, profit after tax stood at ₹3.79Cr (vs ₹-₹7.11Cr in Mar 2026 and ₹4.97Cr in Jun 2025).